ATYR

aTyr Pharma
ATYR

Overview Fund Trends Analyst Outlook Journalist POV

47 hedge funds and large institutions have $75.1M invested in aTyr Pharma in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$8K
Net Calls
Net Calls Change

Top Buyers

1
+$7.02M
2
+$2.23M
3
+$1.56M
4
CC
Checkpoint Capital
California
+$780K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$565K

Top Sellers

1
-$1.36M
2
-$1.18M
3
-$424K
4
Marshall Wace
Marshall Wace
United Kingdom
-$309K
5
PFCS
Pale Fire Capital SE
Czech Republic
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
1 2
3